Cargando…

F201. KINASE NETWORK DYSREGULATION IN SCHIZOPHRENIA: IMPLICATIONS FOR NEW TREATMENT STRATEGIES

BACKGROUND: Disrupted-in-schizophrenia 1 (DISC1) is one of the most substantiated genetic risk factors for schizophrenia (SZ). A large array of animal studies supports an etiopathogenic role of DISC1, by linking it with regulation of processes such as synapse formation and neuronal development. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bentea, Eduard, Depasquale, Erica, Meller, Jarek, Wen, Zhexing, McCullumsmith, Robert E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887319/ http://dx.doi.org/10.1093/schbul/sby017.732

Ejemplares similares

32.2 ABNORMALITIES OF SYNAPTIC PROTEOMES IN SCHIZOPHRENIA
por: Funk, Adam, et al.
Publicado: (2018)

KRSA: An R package and R Shiny web application for an end-to-end upstream kinase analysis of kinome array data
por: DePasquale, Erica A. K., et al.
Publicado: (2021)

S183. ABNORMALITIES IN SERINE/THREONINE SIGNALING NETWORKS IN SEVERE NEUROPSYCHIATRIC ILLNESS: DEVELOPMENT OF A PIPELINE TO EXPLORE ABNORMALITIES OF KINASE ACTIVITY AND IDENTIFY NOVEL TREATMENT STRATEGIES FOR SCHIZOPHRENIA
por: McCullumsmith, Robert, et al.
Publicado: (2020)

12.1 CELL-SUBTYPE SPECIFIC BIOENERGETIC DEFECTS IN SCHIZOPHRENIA
por: Sullivan, Courtney, et al.
Publicado: (2018)

Abnormalities of signal transduction networks in chronic schizophrenia
por: McGuire, Jennifer L., et al.
Publicado: (2017)

Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2019)

Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity
por: Wu, Xiaojun, et al.
Publicado: (2021)

43.3 COMPLEMENT DYSREGULATION IN SCHIZOPHRENIA: IMPLICATIONS FOR POTENTIAL TREATMENT STRATEGIES
por: Beasley, Clare
Publicado: (2018)

F199. O-GLCNAC DYSREGULATION IN SCHIZOPHRENIA CORTEX
por: Mueller, Toni, et al.
Publicado: (2018)

Decreased Chloride Channel Expression in the Dorsolateral Prefrontal Cortex in Schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2015)

F193. DYSREGULATION OF RETINOID SIGNALLING IN SCHIZOPHRENIA OBSERVED IN WHOLE GENOME SEQUENCE ANALYSIS
por: Reay, William, et al.
Publicado: (2018)

Ampa Receptor Subunit Expression in the Endoplasmic Reticulum in Frontal Cortex of Elderly Patients with Schizophrenia
por: Hammond, John C., et al.
Publicado: (2012)

12.2 METABOLIC CONSEQUENCES OF DEVELOPMENTAL NMDA RECEPTOR HYPOFUNCTION
por: Funk, Adam, et al.
Publicado: (2018)

Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
por: Imami, Ali S., et al.
Publicado: (2021)

Protein expression of prenyltransferase subunits in postmortem schizophrenia dorsolateral prefrontal cortex
por: Pinner, Anita L., et al.
Publicado: (2020)

T201. THE STUDY OF WHITE MATTER MATURATION IN THREE POPULATIONS OF GENETIC HIGH RISK FOR SCHIZOPHRENIA INDIVIDUALS SPANNING THE DEVELOPMENTAL TIMELINE
por: Lyall, Amanda, et al.
Publicado: (2018)

SSRIs: Applications in inflammatory lung disease and implications for COVID‐19
por: Meikle, Claire Kyung Sun, et al.
Publicado: (2021)

Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2018)

Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?
por: Hamoud, Abdul-Rizaq, et al.
Publicado: (2022)

Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter
por: Bentea, Eduard, et al.
Publicado: (2020)

Altered purinergic receptor expression in the frontal cortex in schizophrenia
por: Alnafisah, Rawan, et al.
Publicado: (2022)

F198. EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018)

Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia
por: O'Donovan, S M, et al.
Publicado: (2015)

20.1 DISSECTING THE FUNCTIONAL CONSEQUENCES OF RECIPROCAL GENOMIC DISORDERS
por: Talkowski, Michael
Publicado: (2018)

Subcellular partitioning of protein kinase activity revealed by functional kinome profiling
por: Wegman-Points, Lauren, et al.
Publicado: (2022)

10.2 REDOX DYSREGULATION, OLIGODENDROCYTES AND WHITE MATTER ALTERATIONS IN SCHIZOPHRENIA
por: Klauser, Paul, et al.
Publicado: (2018)

S42. KETAMINE DYSREGULATES TASK-RELATED NEURAL OSCILLATIONS IN THALAMO-CORTICAL CIRCUITS: IMPLICATIONS FOR PATHOPHYSIOLOGICAL THEORIES OF VISUAL-PERCEPTUAL DEFICITS IN SCHIZOPHRENIA
por: Grent-’t-Jong, Tineke, et al.
Publicado: (2018)

Physiological Dysregulation and Aging: Implications for Health Equity
por: Forrester, Sarah, et al.
Publicado: (2020)

S201. RELATION BETWEEN PSYCHOTROPIC DRUGS AND SEIZURE THRESHOLD IN ELECTROCONVULSIVE THERAPY
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Physician and Infection Preventionists Perceptions on Communicable Disease Reporting—Indiana, 201
por: Richards, Shawn, et al.
Publicado: (2017)

Aggressiveness and emotion dysregulation among adolescents first degree relatives of schizophrenia patients
por: Ghrissi, F., et al.
Publicado: (2023)

Disclosing the potential impact of placebo controls in antidepressant trials
por: Chen, Stephanie C., et al.
Publicado: (2015)

Using protein turnover to expand the applications of transcriptomics
por: Smail, Marissa A., et al.
Publicado: (2021)

S188. DYSREGULATION OF CIRCULAR RNA EXPRESSION IN SCHIZOPHRENIA OBSERVED IN POSTMORTEM DORSOLATERAL PREFRONTAL CORTEX
por: Mahmoudi, Ebrahim, et al.
Publicado: (2018)

F83. INVESTIGATING THE RELATIONSHIP BETWEEN NEGATIVE SYMPTOM PROFILE AND COGNITIVE FUNCTION IN SCHIZOPHRENIA
por: Yolland, Caitlin, et al.
Publicado: (2018)

PS201. EphB2 in the medial prefrontal cortex regulates vulnerability to stress
por: Zhang, Ruo-Xi, et al.
Publicado: (2016)

201. Outcomes of an Antibiotic Stewardship Team at an Academic Medical Center: 11 Years of Experience
por: Kline, Susan, et al.
Publicado: (2018)

The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders
por: O’Donovan, Sinead M., et al.
Publicado: (2017)

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
por: O’Donovan, Sinead M, et al.
Publicado: (2020)

F149. NEUROBIOLOGY OF SELF-AGENCY DURING REALITY MONITORING AND SPEECH FEEDBACK MONITORING: IMPLICATIONS FOR TREATMENT DEVELOPMENT IN SCHIZOPHRENIA
por: Subramaniam, Karuna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0t00il03cluekq8u18km1pmoaa